Literature DB >> 31431096

Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.

Chan Meng1.   

Abstract

Entities:  

Keywords:  Polycystic ovarian syndrome (PCOS); endothelial dysfunction; meta-analysis; nitric oxide; nitrite; oxidative stress

Mesh：

Substances：

Year:  2019        PMID： 31431096      PMCID： PMC6753550          DOI： 10.1177/0300060519864493

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  32 in total

Review 1.  Actions of tachykinins within the heart and their relevance to cardiovascular disease.

Authors:  D B Hoover; Y Chang; J C Hancock; L Zhang
Journal:  Jpn J Pharmacol       Date:  2000-12

2.  Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.

Authors:  R P Buyalos; M E Geffner; N Bersch; H L Judd; R M Watanabe; R N Bergman; D W Golde
Journal:  Fertil Steril       Date:  1992-04       Impact factor: 7.329

3.  Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.

Authors:  T Sabuncu; H Vural; M Harma; M Harma
Journal:  Clin Biochem       Date:  2001-07       Impact factor: 3.281

4.  Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.

Authors:  K J Mather; S Verma; B Corenblum; T J Anderson
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

5.  Toward a new approach: primary and preventive care of the woman with polycystic ovarian syndrome.

Authors: 
Journal:  Prim Care Update Ob Gyns       Date:  2000-11-01

Review 6.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.

Authors:  E Diamanti-Kandarakis; G Spina; C Kouli; I Migdalis
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.

Authors:  E Carmina
Journal:  Minerva Ginecol       Date:  2004-02

9.  Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.

Authors:  Francesco Orio; Stefano Palomba; Teresa Cascella; Biagio De Simone; Sebastiano Di Biase; Tiziana Russo; Donato Labella; Fulvio Zullo; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

10.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329
View more
  3 in total

1.  Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.

Authors:  Kehinde S Olaniyi; Stephanie E Areloegbe; Mosunmola B Oyeleke
Journal:  Endocrine       Date:  2022-09-16       Impact factor: 3.925

Review 2.  Novel Insights on the Role of Nitric Oxide in the Ovary: A Review of the Literature.

Authors:  Maria Cristina Budani; Gian Mario Tiboni
Journal:  Int J Environ Res Public Health       Date:  2021-01-22       Impact factor: 3.390

3.  Female sexual behavior is disrupted in a preclinical mouse model of PCOS via an attenuated hypothalamic nitric oxide pathway.

Authors:  Mauro S B Silva; Laurine Decoster; Sara Trova; Nour E H Mimouni; Virginia Delli; Konstantina Chachlaki; Qiang Yu; Ulrich Boehm; Vincent Prevot; Paolo Giacobini
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.